Author: Zhai, Xiaofeng; Wang, Shilei; Zhu, Mengyan; He, Wei; Pan, Zhongzhou; Su, Shuo
Title: Antiviral Effect of Lithium Chloride and Diammonium Glycyrrhizinate on Porcine Deltacoronavirus In Vitro Document date: 2019_9_9
ID: 1m5yr8uc_34
Snippet: The viral replication cycle includes attachment, entry, transcription, replication, gene expression, assembly, maturation, and release. We found that DG can inhibit the attachment of the virus to the cell surface, which is consistent with the results of a recent report showing that glycyrrhizin achieved a dose-dependent inhibition of the replication of HIV-1 in MOLT-4 cells, and could interfere with virus-cell binding [37] . However, the specific.....
Document: The viral replication cycle includes attachment, entry, transcription, replication, gene expression, assembly, maturation, and release. We found that DG can inhibit the attachment of the virus to the cell surface, which is consistent with the results of a recent report showing that glycyrrhizin achieved a dose-dependent inhibition of the replication of HIV-1 in MOLT-4 cells, and could interfere with virus-cell binding [37] . However, the specific mechanism needs further investigation. Future experiments will determine if DG can be used not only as a treatment but also for preventing PDCoV infection. Because DG has a good water solubility, it can be used as aerosol disinfectant in piggeries to prevent the outbreak of porcine epidemic diarrhea. According to the antiviral effect, the antiviral activity of LiCl is better than that of DG, and the toxicity of DG is less than that of LiCl. We investigated the effect of LiCl combined with DG on the replication of PDCoV in LLC-PK1 cells. There were no significant differences between LiCl-treated cells and cells treated with LiCl and DG in the mean relative viral mRNA levels, indicating that there is no synergy in the inhibition of viral replication when both drugs are used in combination (data not shown).
Search related documents:
Co phrase search for related documents- antiviral activity and cell surface: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- antiviral activity and dose dependent inhibition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- antiviral activity and drug combination: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- antiviral activity and epidemic diarrhea: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- antiviral activity and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- antiviral activity and LiCl antiviral activity: 1, 2
- antiviral activity and LLC PK1 cell: 1
- antiviral activity and PDCoV infection: 1, 2, 3, 4, 5
- antiviral activity and PDCoV replication: 1, 2, 3
- antiviral activity and porcine epidemic diarrhea: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- antiviral activity and porcine epidemic diarrhea outbreak: 1
- antiviral activity and recent report: 1, 2, 3, 4, 5
- antiviral activity and replication cycle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- antiviral activity and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- antiviral activity and specific mechanism: 1, 2, 3, 4, 5, 6, 7
- antiviral activity and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- antiviral activity and viral replication cycle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- antiviral activity and viral replication inhibition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- antiviral activity and virus attachment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
Co phrase search for related documents, hyperlinks ordered by date